Business Wire

Novaremed’s Non-opioid Lead Compound, NRD.E1, to be Tested in NIH HEAL Initiative Phase 2 Trial for the Treatment of Chronic Pain

BASEL, Switzerland--(BUSINESS WIRE)--Novaremed AG, a privately held clinical-stage biopharmaceutical company, announces a study with the National Institutes of Health (NIH) under which the NIH will ...
PE Hub

NRD closes $104.5 mln for sophomore fund

NRD Capital Management has raised $104.5 million for its second fund, beating its $100 million target. The fund will focus on backing restaurant and healthcare franchises. ATLANTA, GA – July 12, 2017 ...
Business Wire

Novaremed Announces Publication of Phase 1 and Phase 2a Study Data With NRD.E1 Demonstrating the Potential of This Investigational Non-opioid Pain Treatment

BASEL, Switzerland--(BUSINESS WIRE)--Novaremed AG, a privately held clinical-stage biopharmaceutical company focused on innovative non-opioid treatment options for chronic pain management announces ...
Franchise Times

Frisch's Last Two Family Execs Gain Exit Via NRD

Frisch’s Restaurants is the first acquisition for NRD Partners, the Atlanta-based private equity fund launched last August by CEO Aziz Hashim. It’s the first private equity owner in Frisch’s history.
Nation's Restaurant News

NRD Capital closes on a $100M restaurant fund

Aziz Hashim has only been a private-equity investor for three years, but he’s already attracting more interested investors than he expected. The former Popeyes, Domino’s and Checkers franchisee ...